243 related articles for article (PubMed ID: 24628404)
1. Culture duration-, donor-, and medium-dependent changes in OATP1B3-mediated telmisartan uptake in human hepatocytes.
Zhu Q; Xia H; Xia CQ; Yang Q; Doshi U; Li AP; Liao M
Drug Metab Lett; 2014 Jul; 7(2):117-25. PubMed ID: 24628404
[TBL] [Abstract][Full Text] [Related]
2. Predominant contribution of OATP1B3 to the hepatic uptake of telmisartan, an angiotensin II receptor antagonist, in humans.
Ishiguro N; Maeda K; Kishimoto W; Saito A; Harada A; Ebner T; Roth W; Igarashi T; Sugiyama Y
Drug Metab Dispos; 2006 Jul; 34(7):1109-15. PubMed ID: 16611857
[TBL] [Abstract][Full Text] [Related]
3. Preclinical Mouse Models To Study Human OATP1B1- and OATP1B3-Mediated Drug-Drug Interactions in Vivo.
Durmus S; Lozano-Mena G; van Esch A; Wagenaar E; van Tellingen O; Schinkel AH
Mol Pharm; 2015 Dec; 12(12):4259-69. PubMed ID: 26474710
[TBL] [Abstract][Full Text] [Related]
4. Functional characterization for polymorphic organic anion transporting polypeptides (OATP/SLCO1B1, 1B3, 2B1) of monkeys recombinantly expressed with various OATP probes.
Takahashi T; Uno Y; Yamazaki H; Kume T
Biopharm Drug Dispos; 2019 Feb; 40(2):62-69. PubMed ID: 30652318
[TBL] [Abstract][Full Text] [Related]
5. Pre-incubation with OATP1B1 and OATP1B3 inhibitors potentiates inhibitory effects in physiologically relevant sandwich-cultured primary human hepatocytes.
Farasyn T; Pahwa S; Xu C; Yue W
Eur J Pharm Sci; 2021 Oct; 165():105951. PubMed ID: 34311070
[TBL] [Abstract][Full Text] [Related]
6. Establishment of a set of double transfectants coexpressing organic anion transporting polypeptide 1B3 and hepatic efflux transporters for the characterization of the hepatobiliary transport of telmisartan acylglucuronide.
Ishiguro N; Maeda K; Saito A; Kishimoto W; Matsushima S; Ebner T; Roth W; Igarashi T; Sugiyama Y
Drug Metab Dispos; 2008 Apr; 36(4):796-805. PubMed ID: 18180273
[TBL] [Abstract][Full Text] [Related]
7. Organic anion transporting polypeptides 1B1 and 1B3 play an important role in uremic toxin handling and drug-uremic toxin interactions in the liver.
Sato T; Yamaguchi H; Kogawa T; Abe T; Mano N
J Pharm Pharm Sci; 2014; 17(4):475-84. PubMed ID: 25579430
[TBL] [Abstract][Full Text] [Related]
8. Characterization of organic anion transporting polypeptide (OATP) expression and its functional contribution to the uptake of substrates in human hepatocytes.
Kimoto E; Yoshida K; Balogh LM; Bi YA; Maeda K; El-Kattan A; Sugiyama Y; Lai Y
Mol Pharm; 2012 Dec; 9(12):3535-42. PubMed ID: 23082789
[TBL] [Abstract][Full Text] [Related]
9. Prediction of organic anion-transporting polypeptide 1B1- and 1B3-mediated hepatic uptake of statins based on transporter protein expression and activity data.
Kunze A; Huwyler J; Camenisch G; Poller B
Drug Metab Dispos; 2014 Sep; 42(9):1514-21. PubMed ID: 24989890
[TBL] [Abstract][Full Text] [Related]
10. Relative Activity Factor (RAF)-Based Scaling of Uptake Clearance Mediated by Organic Anion Transporting Polypeptide (OATP) 1B1 and OATP1B3 in Human Hepatocytes.
Izumi S; Nozaki Y; Kusuhara H; Hotta K; Mochizuki T; Komori T; Maeda K; Sugiyama Y
Mol Pharm; 2018 Jun; 15(6):2277-2288. PubMed ID: 29746136
[TBL] [Abstract][Full Text] [Related]
11. Drug and bile acid transporters in rosuvastatin hepatic uptake: function, expression, and pharmacogenetics.
Ho RH; Tirona RG; Leake BF; Glaeser H; Lee W; Lemke CJ; Wang Y; Kim RB
Gastroenterology; 2006 May; 130(6):1793-806. PubMed ID: 16697742
[TBL] [Abstract][Full Text] [Related]
12. Treatment with proteasome inhibitor bortezomib decreases organic anion transporting polypeptide (OATP) 1B3-mediated transport in a substrate-dependent manner.
Alam K; Farasyn T; Crowe A; Ding K; Yue W
PLoS One; 2017; 12(11):e0186924. PubMed ID: 29107984
[TBL] [Abstract][Full Text] [Related]
13. Evaluation of organic anion transporting polypeptide 1B1 and 1B3 humanized mice as a translational model to study the pharmacokinetics of statins.
Salphati L; Chu X; Chen L; Prasad B; Dallas S; Evers R; Mamaril-Fishman D; Geier EG; Kehler J; Kunta J; Mezler M; Laplanche L; Pang J; Rode A; Soars MG; Unadkat JD; van Waterschoot RA; Yabut J; Schinkel AH; Scheer N
Drug Metab Dispos; 2014 Aug; 42(8):1301-13. PubMed ID: 24855184
[TBL] [Abstract][Full Text] [Related]
14. Isolation of modulators of the liver-specific organic anion-transporting polypeptides (OATPs) 1B1 and 1B3 from Rollinia emarginata Schlecht (Annonaceae).
Roth M; Araya JJ; Timmermann BN; Hagenbuch B
J Pharmacol Exp Ther; 2011 Nov; 339(2):624-32. PubMed ID: 21846839
[TBL] [Abstract][Full Text] [Related]
15. Expression and transport function of drug uptake transporters in differentiated HepaRG cells.
Kotani N; Maeda K; Debori Y; Camus S; Li R; Chesne C; Sugiyama Y
Mol Pharm; 2012 Dec; 9(12):3434-41. PubMed ID: 22897388
[TBL] [Abstract][Full Text] [Related]
16. OATP1B3 Expression and Function is Modulated by Coexpression with OCT1, OATP1B1, and NTCP.
Zhang Y; Ruggiero M; Hagenbuch B
Drug Metab Dispos; 2020 Aug; 48(8):622-630. PubMed ID: 32482756
[TBL] [Abstract][Full Text] [Related]
17. Digoxin is not a substrate for organic anion-transporting polypeptide transporters OATP1A2, OATP1B1, OATP1B3, and OATP2B1 but is a substrate for a sodium-dependent transporter expressed in HEK293 cells.
Taub ME; Mease K; Sane RS; Watson CA; Chen L; Ellens H; Hirakawa B; Reyner EL; Jani M; Lee CA
Drug Metab Dispos; 2011 Nov; 39(11):2093-102. PubMed ID: 21849517
[TBL] [Abstract][Full Text] [Related]
18. Expression of organic anion-transporting polypeptides 1B1 and 1B3 in ovarian cancer cells: relevance for paclitaxel transport.
Svoboda M; Wlcek K; Taferner B; Hering S; Stieger B; Tong D; Zeillinger R; Thalhammer T; Jäger W
Biomed Pharmacother; 2011 Sep; 65(6):417-26. PubMed ID: 21719246
[TBL] [Abstract][Full Text] [Related]
19. Substrate-dependent drug-drug interactions between gemfibrozil, fluvastatin and other organic anion-transporting peptide (OATP) substrates on OATP1B1, OATP2B1, and OATP1B3.
Noé J; Portmann R; Brun ME; Funk C
Drug Metab Dispos; 2007 Aug; 35(8):1308-14. PubMed ID: 17470528
[TBL] [Abstract][Full Text] [Related]
20. Evaluation of a potential transporter-mediated drug interaction between rosuvastatin and pradigastat, a novel DGAT-1 inhibitor.
Kulmatycki K; Hanna I; Meyers D; Salunke A; Movva A; Majumdar T; Natrillo A; Vapurcuyan A; Rebello S; Sunkara G; Chen J
Int J Clin Pharmacol Ther; 2015 May; 53(5):345-55. PubMed ID: 25740267
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
